"What does it require to bring a transformational innovation to patients?" begins the study conducted by the University of California, Los Angeles (UCLA).
The UCLA Biodesign Hub for MedTech and Digital Health is a regional network that promotes the technological advancement and progress of digital health technologies with commercialization potential.
The UCLA Initiative was the creation of an industry-wide study of the medical and digital health industry to understand costs and timescales for approval and regulation of technological advances in medicine. The study is supported by the Economic Development Administration (EDA).
Through www.medtechstudy.com UCLA is seeking digital health companies, experts, medical technology executives, and thought leaders in this technology to participate in its study on the impact of reimbursement regulation from 2010 to 2020 through 30-minute interviews.
The participant must choose a medical or digital health device approved in the United States by the FDA between 2010 and 2020.
The interviews include the following questions:
- How long does it really take innovations to get to market?
- Do digital health and AI / ML have a clear path to market?
- Is breakthrough designation breaking down regulatory barriers to access?
- Is reimbursement the new barrier to innovation?
- Is the U.S. keeping pace with Europe, Japan, and China?
- What is next on the regulatory and reimbursement horizon?
